论文部分内容阅读
目的研究清开灵、利多卡因注射液对椎基底动脉供血不足的治疗效果。方法本次研究选取的研究对象为2014年12月至2015年12月期间在我院进行治疗的椎基底动脉供血不足患者,将60例患者简单随机分为2组,30例/组。常规药物治疗(对照组),在此基础上采用清开灵、利多卡因注射液治疗(观察组)。对比两组椎基底动脉供血不足患者的实验室指标和复发率。结果治疗后观察组椎基底动脉供血不足患者的上述指标均优于对照组患者(P<0.05)。结论清开灵、利多卡因注射液能够有效改善椎基底动脉供血不足患者的临床症状和实验室指标,降低复发率,适合在临床上推广使用。
Objective To study the therapeutic effect of Qingkailing and lidocaine injection on vertebrobasilar insufficiency. Methods The subjects selected in this study were patients with vertebrobasilar insufficiency who were treated in our hospital from December 2014 to December 2015. The 60 patients were randomly divided into 2 groups (30 cases / group). Conventional drug treatment (control group), on this basis, the use of Qing Kai Ling, lidocaine injection treatment (observation group). The laboratory indexes and recurrence rates of two patients with vertebrobasilar insufficiency were compared. Results After treatment, the above indexes in patients with vertebrobasilar insufficiency in the observation group were better than those in the control group (P <0.05). Conclusion Qingkailing and lidocaine injection can effectively improve the clinical symptoms and laboratory indexes of patients with vertebrobasilar insufficiency and reduce the recurrence rate, which is suitable for clinical use.